Publications by authors named "J Goulle"
Cannabidiol (CBD) is a phytocannabinoid present in cannabis, obtained either by extraction from the plant or by synthesis. The latter has the advantage of being pure and contains few impurities, unlike CBD of plant origin. It is used by inhalation, ingestion or skin application.
View Article and Find Full Text PDFArticle Synopsis
- The French authorities requested recommendations for screening and managing exposure to inorganic arsenic (iAs) for the population, leading to a review of existing literature on the indicators of exposure and effects in France.
- Evaluating the toxicity of iAs involved examining studies from the past 30 years, including recent literature from 2016 to 2019.
- The recommended biomonitoring indicator for iAs exposure is a specific urine concentration measurement, with set limits indicating overexposure; no biological indicators for early health effects exist, but skin issues like hyperpigmentation are noted as early signs of harm.
[Recreational use of cannabis: From effects to harm. Epidemiological data].
Bull Acad Natl Med
June 2020
As the medical use of so-called "therapeutic cannabis" is in the process of being approved in France, the opening to its recreational use is the next logical step, as it has been always the chronology followed in all countries. Indeed, those who have legalized the drug have previously approved its therapeutic use. This "justifying a project phase" stage seems unavoidable.
View Article and Find Full Text PDF